Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients in Teodoro Maldonado Carbo Specialty's Hospital Infected and Diagnosed by SARS-Cov-2 With COVID-19

NCT04407182 is registered in ClinicalTrials.gov with Catalysis SL as lead sponsor.

NCT NCT04407182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04407182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients in Teodoro Maldonado Carbo Specialty's Hospital Infected and Diagnosed by SARS-Cov-2 With COVID-19
Lead sponsor
Catalysis SL
Phase
Phase 2
Overall status
Completed
Start date
May 4, 2020
Completion date
October 1, 2020
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiopathy, covid-19, diabete mellitus, liver diseases, pulmonary disease, renal disease, sars-cov2